MENICON Z(TM) (TISILFOCON A) RIGID GAS PERMEABLE CONTACT LENS FOR 30-DAY EXTENDED WEAR

Lens, Contact (rigid Gas Permeable), Extended Wear

FDA Premarket Approval P990018 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the menicon z (tisilfocon a) rigid gas permeable contact lens. This device is indicated for: menicon z (tisilfocon a) spherical, aspheric, non-prism ballast toric and non-prism ballast multifocal lenses are indicated for extended wear (from 1 to 30 days between removals for cleaning and disinfection of the lenses, as recommended by the eyecare professional) for the correction of refractive error (myopia, hyperopia, presbyopia and/or astigmatism) in non-aphakic persons with non-diseased eyes. The lens may be prescribed in spherical and aspheric powers ranging from -25. 00 d to +25. 00 d for daily wear and -25. 00 d to +8. 00 d for up to 30 days extended wear. Toric lenses are designed to correct up to 5. 00 d of astigmatism and multifocal lenses to provide up to +3. 00 d of reading add power for up to 30 days extended wear. The lens may be disinfected using a chemical disinfection system only. (the menicon z (tisilfocon a) rigid gas permeable contact lens was cleared for daily wear under k962006, k970019 and k972443).

DeviceMENICON Z(TM) (TISILFOCON A) RIGID GAS PERMEABLE CONTACT LENS FOR 30-DAY EXTENDED WEAR
Classification NameLens, Contact (rigid Gas Permeable), Extended Wear
Generic NameLens, Contact (rigid Gas Permeable), Extended Wear
ApplicantMENICON CO. LTD.
Date Received2001-11-28
Decision Date2002-07-12
Notice Date2002-08-06
PMAP990018
SupplementS002
Product CodeMWL
Docket Number02M-0335
Advisory CommitteeOphthalmic
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address MENICON CO. LTD. 269 A Ballardvale Street wilmington, MA 01887
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990018Original Filing
S008 2022-02-07 Normal 180 Day Track
S007
S006 2021-01-21 Normal 180 Day Track No User Fee
S005 2018-11-28 Normal 180 Day Track
S004 2009-04-01 Normal 180 Day Track No User Fee
S003 2002-10-21 Real-time Process
S002 2001-11-28 Panel Track
S001 2000-07-28 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.